Funding Rounds
Evommune

Evommune October 2024 Series C Funding Round

Evommune

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series C

Raised Amount: $115.00M

Raised Date: 2024-10-31

Investors